NO2006013I1 - Humant parathyreoidahormon (humant parathyroid hormon) - Google Patents

Humant parathyreoidahormon (humant parathyroid hormon)

Info

Publication number
NO2006013I1
NO2006013I1 NO2006013C NO2006013C NO2006013I1 NO 2006013 I1 NO2006013 I1 NO 2006013I1 NO 2006013 C NO2006013 C NO 2006013C NO 2006013 C NO2006013 C NO 2006013C NO 2006013 I1 NO2006013 I1 NO 2006013I1
Authority
NO
Norway
Prior art keywords
parathyroid hormone
human parathyroid
human
ultrapure
hormone
Prior art date
Application number
NO2006013C
Other languages
English (en)
Other versions
NO2006013I2 (no
Original Assignee
Nps Allelix Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24840399&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO2006013(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nps Allelix Corp filed Critical Nps Allelix Corp
Publication of NO2006013I1 publication Critical patent/NO2006013I1/no
Publication of NO2006013I2 publication Critical patent/NO2006013I2/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Glass Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO2006013C 1991-05-23 2006-10-24 Humant parathyreoidahormon (Humant parathyroid hormon) NO2006013I2 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/707,114 US5208041A (en) 1991-05-23 1991-05-23 Essentially pure human parathyroid hormone

Publications (2)

Publication Number Publication Date
NO2006013I1 true NO2006013I1 (no) 2006-11-06
NO2006013I2 NO2006013I2 (no) 2009-12-07

Family

ID=24840399

Family Applications (2)

Application Number Title Priority Date Filing Date
NO19922000A NO304190B1 (no) 1991-05-23 1992-05-21 Rent parathyroid hormon, fremgangsmÕte for dets fremstilling samt farmasoytisk sammensetning inneholdende det
NO2006013C NO2006013I2 (no) 1991-05-23 2006-10-24 Humant parathyreoidahormon (Humant parathyroid hormon)

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO19922000A NO304190B1 (no) 1991-05-23 1992-05-21 Rent parathyroid hormon, fremgangsmÕte for dets fremstilling samt farmasoytisk sammensetning inneholdende det

Country Status (16)

Country Link
US (1) US5208041A (no)
EP (1) EP0515228B1 (no)
JP (1) JP2563726B2 (no)
KR (1) KR970007755B1 (no)
AT (1) ATE164394T1 (no)
CA (1) CA2068438C (no)
DE (1) DE69224858T2 (no)
DK (1) DK0515228T3 (no)
ES (1) ES2115642T3 (no)
FI (1) FI106802B (no)
HK (1) HK1004340A1 (no)
IE (1) IE921672A1 (no)
IL (3) IL101829A (no)
NO (2) NO304190B1 (no)
NZ (1) NZ242855A (no)
ZA (1) ZA923735B (no)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5420242A (en) * 1986-10-22 1995-05-30 Kaare M. Gautvik Production of human parathyroid hormone from microorganisms
USRE37919E1 (en) 1989-05-12 2002-12-03 The General Hospital Corporation Recombinant DNA method for production of parathyroid hormone
TW273513B (no) * 1993-10-27 1996-04-01 Chugai Pharmaceutical Co Ltd
US20020193338A1 (en) * 1994-02-18 2002-12-19 Goldstein Steven A. In vivo gene transfer methods for wound healing
US5962427A (en) 1994-02-18 1999-10-05 The Regent Of The University Of Michigan In vivo gene transfer methods for wound healing
US6074840A (en) 1994-02-18 2000-06-13 The Regents Of The University Of Michigan Recombinant production of latent TGF-beta binding protein-3 (LTBP-3)
US5763416A (en) 1994-02-18 1998-06-09 The Regent Of The University Of Michigan Gene transfer into bone cells and tissues
US5942496A (en) 1994-02-18 1999-08-24 The Regent Of The University Of Michigan Methods and compositions for multiple gene transfer into bone cells
US6551618B2 (en) 1994-03-15 2003-04-22 University Of Birmingham Compositions and methods for delivery of agents for neuronal regeneration and survival
AU745122B2 (en) 1997-07-30 2002-03-14 Emory University Novel bone mineralization proteins, DNA, vectors, expression systems
US7923250B2 (en) 1997-07-30 2011-04-12 Warsaw Orthopedic, Inc. Methods of expressing LIM mineralization protein in non-osseous cells
US6770623B1 (en) 1997-12-09 2004-08-03 Eli Lilly And Company Stabilized teriparatide solutions
DZ2873A1 (fr) 1998-08-19 2003-12-15 Lilly Co Eli Procédé pour augmenter la dureté et la rigidité osseuse.
US6495662B1 (en) * 1998-10-22 2002-12-17 The General Hospital Corporation Bioactive peptides and peptide derivatives of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP)
AU4217299A (en) * 1998-11-30 2000-06-19 General Hospital Corporation, The Pth1r and pth3r receptors, methods and uses thereof
US7820393B2 (en) * 1999-01-14 2010-10-26 Scantibodies Laboratory, Inc. Methods, kits and antibodies for detecting parathyroid hormone
US6689566B1 (en) 1999-01-14 2004-02-10 Scantibodies Laboratory, Inc. Methods, kits, and antibodies for detecting parathyroid hormone
WO2004028444A2 (en) * 1999-06-02 2004-04-08 Scantibodies Laboratory, Inc. Parathyroid hormone antagonists and uses thereof
US20080108086A1 (en) * 1999-06-02 2008-05-08 Cantor Thomas L Parathyroid hormone antagonists and uses thereof
AU7734800A (en) * 1999-09-29 2001-04-30 General Hospital Corporation, The Polypeptide derivatives of parathyroid hormone (pth)
MY136546A (en) * 2000-06-30 2008-10-31 Asubio Pharma Co Ltd A pharmaceutical component based on human parathyroid harmone and a pharmaceutical composition for intranasal administration comprising the component
US6387711B1 (en) * 2000-08-11 2002-05-14 Quest Diagnostics Investments Incorporated Liquid intact parathyroid hormone (PTH) standards
US6905886B2 (en) * 2000-08-11 2005-06-14 Quest Diagnostics Investments Incorporated Preservative solutions
JP4837888B2 (ja) * 2001-07-23 2011-12-14 ザ ジェネラル ホスピタル コーポレイション コンホメーションが拘束された副甲状腺ホルモン（ｐｔｈ）類似体
US20040067526A1 (en) * 2002-10-03 2004-04-08 Cantor Thomas L. Methods for diagnosing and guiding treatment of bone turnover disease
EP1610813A4 (en) * 2003-03-19 2009-07-01 Gen Hospital Corp PARATHYROIDAL HORMONES CONFORMALLY CONFORMALLY CONSTRAINED WITH PROPELLER STABILIZERS $ G (A)
KR100540659B1 (ko) * 2003-07-02 2006-01-10 삼성전자주식회사 이미지 확대 인쇄 방법과 장치 및 컴퓨터 프로그램을저장하는 컴퓨터로 읽을 수 있는 기록 매체
WO2005009358A2 (en) 2003-07-17 2005-02-03 The General Hospital Corporation Conformationally constrained parathyroid hormone (pth) analogs
BRPI0509788A (pt) 2004-05-13 2007-10-23 Alza Corp aparato e método para liberação transdérmica de agentes de hormÈnio paratireóides
US7541140B2 (en) * 2004-06-03 2009-06-02 Scantibodies Laboratory, Inc. Assessing risk for kidney stones using parathyroid hormone agonist and antagonist
AU2006315132A1 (en) * 2005-11-10 2007-05-24 Board Of Control Of Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
EP2054077A4 (en) * 2006-08-04 2010-10-13 Gen Hospital Corp POLYPEPTIDE DERIVATIVES OF PARATHYROID HORMONE (PTH)
AU2008282805B2 (en) * 2007-08-01 2014-05-01 Chugai Pharmaceutical Co., Ltd. Screening methods using G-protein coupled receptors and related compositions
US8298789B2 (en) * 2007-08-09 2012-10-30 Usv Limited Orthogonal process for purification of recombinant human parathyroid hormone (rhPTH) (1-34)
CN102471368A (zh) * 2009-08-11 2012-05-23 拜康有限公司 色谱方法及其纯化的化合物
EP2509996A1 (en) 2009-12-07 2012-10-17 Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
BR112012028949B1 (pt) 2010-05-13 2020-11-17 Chugai Seiyaku Kabushiki Kaisha polipeptídeo análogo do hormônio paratireoideo, seu uso e método de produção, bem como ácido nucleico, vetor de expressão, célula e composição farmacêutica
CN108195965B (zh) * 2011-06-07 2021-02-23 旭化成制药株式会社 含pth肽冷冻干燥制剂的检査方法及包含该含pth肽冷冻干燥制剂的医药品的制造方法
CN102993293B (zh) * 2012-12-05 2014-05-07 深圳翰宇药业股份有限公司 一种特立帕肽醋酸盐的纯化方法
LU100168B1 (en) 2017-04-12 2018-10-15 Michael Pazianas Prevention of Bone and Mineral Disorders by Restoring Calcium and Phosphate Homeostasis in Patients Suffering from Chronic Kidney Disease
CN115279396A (zh) 2020-03-30 2022-11-01 四川泸州步长生物制药有限公司 人类甲状旁腺激素(pth)的制剂及用于生产其的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3886132A (en) * 1972-12-21 1975-05-27 Us Health Human parathyroid hormone
US5223407A (en) * 1988-08-31 1993-06-29 Allelix Inc. Excretion of heterologous proteins from e. coli
WO1991005050A1 (en) * 1989-09-29 1991-04-18 Her Majesty In Right Of Canada As Represented By The National Research Council Of Canada Synthesis of mature human parathyroid hormone

Also Published As

Publication number Publication date
AU1604992A (en) 1993-03-11
JP2563726B2 (ja) 1996-12-18
IL119840A0 (en) 1997-03-18
HK1004340A1 (en) 1998-11-20
ZA923735B (en) 1993-01-27
NO2006013I2 (no) 2009-12-07
NO304190B1 (no) 1998-11-09
US5208041A (en) 1993-05-04
KR970007755B1 (en) 1997-05-16
CA2068438A1 (en) 1992-11-24
AU639856B2 (en) 1993-08-05
ATE164394T1 (de) 1998-04-15
NZ242855A (en) 1994-04-27
CA2068438C (en) 1996-11-12
FI922356A (fi) 1992-11-24
DE69224858D1 (de) 1998-04-30
FI106802B (fi) 2001-04-12
EP0515228A3 (no) 1994-05-04
ES2115642T3 (es) 1998-07-01
NO922000L (no) 1992-11-24
EP0515228A2 (en) 1992-11-25
DK0515228T3 (da) 1998-09-28
IL119840A (en) 2005-08-31
IE921672A1 (en) 1992-12-02
JPH0687897A (ja) 1994-03-29
FI922356A0 (fi) 1992-05-22
EP0515228B1 (en) 1998-03-25
IL101829A0 (en) 1992-12-30
NO922000D0 (no) 1992-05-21
DE69224858T2 (de) 1998-07-23
IL101829A (en) 1999-12-31

Similar Documents

Publication Publication Date Title
NO2006013I2 (no) Humant parathyreoidahormon (Humant parathyroid hormon)
DE3876273D1 (de) Isoelektrisches fokussierverfahren sowie einrichtung zur durchfuehrung dieses verfahrens.
DE3680997D1 (de) Einrichtung zur als sprache empfundenen rueckkopplung.
DE219220T1 (de) Verfahren und zusammensetzung zur gleichzeitigen reinigung und desinfektion von kontaktlinsen.
DE3682249D1 (de) Verfahren zur bildbearbeitung und geraet zur bilderzeugung.
ES2055445T3 (es) Proteinas de fusion que comprenden gm-csf e il-3.
NO901026L (no) Anordning og fremgangsmaate for naturlig spraakanalysering.
DE3853301T2 (de) Verfahren und Vorrichtung zur Positionierung von Vorlagen in Bildabtastern.
DE3685043D1 (de) Linsenmessgeraet und messverfahren dazu fuer gleitsichtlinsen.
DE3562815D1 (de) Oparation device for valves
ATE148923T1 (de) Funktioneller test und reagenz zur bestimmung von fibrinogen
DE3662077D1 (de) A lorgnette frame
GR851623B (no)
DE3787723T2 (de) Gerät zur kontaminationsanalyse.
IT8467198A1 (it) Metodo e dispositivo per il controllo dei processi di saldatura mediante l'analisi della luminosita' generata durante il processo.
DK639089D0 (da) Fremgangsmaade til oploeseliggoerelse og naturering af somatotropin
NO860381L (no) Fremgangsmaate og anordning for bildebehandling.
DK232988A (da) Fremgangsmaade til immunologisk bestemmelse af aminoterminalt prokollagen peptidtype iii og antistoffer til gennemfoerelse heraf.
FR2714768B1 (fr) Dispositif de balayage électronique à lentille active et source illuminatrice intégrée.
DE69122612D1 (de) Interleukin-4-bindeprotein-gamma
DE69126519T2 (de) Kapillarelektrophoreseverfahren und Vorrichtung dafür

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: SHIRE-NPS PHARMACEUTICALS, US